Weight-Loss drug could boost IVF success for overweight women
NCT ID NCT07242534
Summary
This study is testing whether taking the weight-loss medication semaglutide for 12 weeks before IVF treatment improves embryo quality in overweight and obese women. Researchers want to see if this pre-treatment leads to more high-quality embryos compared to standard IVF without the medication. The goal is to help improve fertility treatment outcomes for women struggling with both weight and infertility.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus
RECRUITINGBarcelona, 08028, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Reus
NOT_YET_RECRUITINGReus, Tarragona, 43202, Spain
Contact Email: •••••@•••••
Contact
-
Dexeus Mujer Sabadell
NOT_YET_RECRUITINGSabadell, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Sant Cugat
NOT_YET_RECRUITINGSant Cugat del Vallès, Barcelona, 08195, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dexeus Mujer Tarragona
NOT_YET_RECRUITINGTarragona, 43206, Spain
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.